Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TISSUE POLYPEPTIDE ANTIGEN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 184 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gattegno, B; Chopin, D
      Diagnosis

      PROGRES EN UROLOGIE
    2. Bancher-Todesca, D; Hefler, L; Zeisler, H; Schatten, C; Husslein, P; Heinze, G; Tempfer, C
      Placental expression of cytokeratin 18 and serum levels of tissue polypeptide antigen in women with pregnancy-induced hypertension

      HYPERTENSION IN PREGNANCY
    3. Gadducci, A; Ferdeghini, M; Cosio, S; Fanucchi, A; Cristofani, R; Genazzani, AR
      The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    4. Soletormos, G
      Serological tumor markers for monitoring breast cancer

      DANISH MEDICAL BULLETIN
    5. Tuxen, MK
      Tumor marker CA125 in ovarian cancer

      JOURNAL OF TUMOR MARKER ONCOLOGY
    6. Kausch, I; Bohle, A
      Bladder cancer II. Molecular aspects and diagnosis

      EUROPEAN UROLOGY
    7. Ando, S; Kimura, H; Iwai, N; Nomoto, Y; Shima, M; Ando, M; Kuriyama, T
      Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer

      ANTICANCER RESEARCH
    8. Cioffi, M; Vietri, MT; Gazzerro, P; Magnetta, R; D'Auria, A; Durante, A; Nola, E; Puca, GA; Molinari, AM
      Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers

      LUNG CANCER
    9. D'Alessandro, R; Roselli, M; Ferroni, P; Mariotti, S; Spila, A; Aloe, S; Carone, MD; Abbolito, MR; Carlini, S; Perri, P; Ricciotti, A; Botti, C; Conti, F; Vici, P; Chiappetta, NR; Cognetti, F; Buonomo, O; Guadagni, F
      Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    10. Rebhandl, W; Handisurya, A; Memaran, N; Felberbauer, FX; Aberle, J; Paya, K; Strobl, B; Horcher, E
      Expression of cytokeratin-18-related tissue polypeptide-specific (TPS) antigen in Wilms tumor

      MEDICAL AND PEDIATRIC ONCOLOGY
    11. Yao, WJ; Chang, TT; Wang, ST; Chow, NH; Lin, PW; Chang, YC; Tu, DG; Chiu, NT
      Clinicopathologic correlation of serum tissue polypeptide specific antigenin hepatocellular carcinoma

      ONCOLOGY
    12. Soletormos, G; Bach, F
      Cerebrospinal fluid cytokeratins for diagnosis of patients with central nervous system metastases from breast cancer

      CLINICAL CHEMISTRY
    13. Kassim, SK; Fawzy, H; El Rassad, MM; Khalil, FK; Khalifa, A
      Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients

      CLINICAL BIOCHEMISTRY
    14. Tuxen, MK; Soletormos, G; Dombernowsky, P
      Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

      BRITISH JOURNAL OF CANCER
    15. Findeisen, R; Albrecht, S; Richter, B; Deutschmann, K; Zimmermann, T; Distler, W
      Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison withvascular endothelial growth factor (VEGF) in follow-up of breast cancer

      LUMINESCENCE
    16. Soletormos, G; Petersen, PH; Dombernowsky, P
      Assessment of CA 15.3, CEA and TPA concentrations during monitoring of breast cancer

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    17. Hefler, L; Tempfer, C; Frischmuth, K; Maenner, G; Concin, N; Sliutz, G; Reinthaller, A; Leodolter, S; Kainz, C
      Serum concentrations of tissue polypeptide antigen in patients with vulvarintraepithelial neoplasia and vulvar cancer

      TUMOR BIOLOGY
    18. Theyer, G; Ulsperger, E; Baumgartner, G; Raderer, M; Hamilton, G
      Prolonged response to a single androgen suppression phase in a subpopulation of prostate cancer patients

      ANNALS OF ONCOLOGY
    19. Hirschberg, L; Bezzegh, A; Aronsson, AC
      LIAISON (R) TPA, the automated chemiluminescence immunoassay for the determination of cytokeratins 8, 18 and 19

      JOURNAL OF TUMOR MARKER ONCOLOGY
    20. Prados, C; Alvarez-Sala, R; de Terreros, JG; Callol, L; Rio, FG; Carrera, LG; Caro, JGD; Alvarez-Sala, JL; Espinos, D; Villamor, J
      An evaluation of tissue polypeptide antigen (TPA) in the two bronchoalveolar lavage fractions of lung cancer patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    21. Ho, YJ; Hsieh, JF; Tasi, SC; Lee, JK; Kao, CH
      Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma

      LUNG
    22. Sun, SS; Hsieh, JF; Tsai, SC; Ho, YJ; Kao, CH
      Tissue polypeptide-specific antigen and carcinoembryonic antigen for earlyprediction of recurrence in lung adenocarcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    23. Wolff, JM; Rohde, D; Borchers, H; Jakse, G
      Tissue polypeptide specific antigen serum concentrations in patients with newly diagnosed prostatic diseases

      ANTICANCER RESEARCH
    24. Sun, SS; Hsieh, JF; Tsai, SC; Ho, YJ; Kao, CH
      Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma

      ANTICANCER RESEARCH
    25. Buccheri, G; Ferrigno, D
      Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer:a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase

      LUNG CANCER
    26. Gion, M; Boracchi, P; Dittadi, R; Biganzoli, E; Peloso, L; Gatti, C; Paccagnella, A; Rosabian, A; Vinante, O; Meo, S
      Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possiblyassociated with apoptosis

      BREAST CANCER RESEARCH AND TREATMENT
    27. Gonzalez-Quintela, A; Mella, C; Perez, LF; Abdulkader, I; Caparrini, AM; Lojo, S
      Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: Apossible marker of alcoholic hepatitis

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    28. Gaarenstroom, KN; Kenter, GG; Bonfrer, JMG; Korse, CM; Van de Vijver, MJ; Fleuren, GJ; Trimbos, JB
      Can initial serum Cyfra 21-1, SCC antigen, and TPA levels in squamous cellcervical cancer predict lymph node metastases or prognosis?

      GYNECOLOGIC ONCOLOGY
    29. Tempfer, CB; Bancher-Todesca, D; Zeisler, H; Schatten, C; Husslein, P; Gregg, AR
      Placental expression and serum concentrations of cytokeratin 19 in preeclampsia

      OBSTETRICS AND GYNECOLOGY
    30. Fuhrman, C; Duche, JC; Chouaid, C; Abd Alsamad, I; Atassi, K; Monnet, I; Tillement, JP; Housset, B
      Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies

      CLINICAL BIOCHEMISTRY
    31. Akbay, A; Bozbas, A; Isgor, Y; Yavuz, Y; Elgun, S
      Serum dipeptidylpeptidase activity and tissue polypeptide specific antigenin patients with advanced cirrhosis: preliminary results

      CLINICA CHIMICA ACTA
    32. Slesak, B; Harlozinska-Szmyrka, A; Knast, W; Sedlaczek, P; van Dalen, A; Einarsson, R
      Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis - A comparative study with CA 19-9

      CANCER
    33. Kausch, I; Bohle, A
      Molecular aspects of bladder carcinoma part II. Molecular diagnostics

      AKTUELLE UROLOGIE
    34. Durkan, GC; Brotherick, I; Mellon, JK
      The impact of transurethral resection of bladder tumour on serum levels ofsoluble E-cadherin

      BJU INTERNATIONAL
    35. Einarsson, P; Barak, V
      TPS (TM): A cytokeratin serum tumor marker for effective therapy control of cancer patients with focus on breast cancer

      JOURNAL OF CLINICAL LIGAND ASSAY
    36. Jorgensen, LGM
      Neuron specific enolase in small cell lung cancer - Clinical and biochemical evaluation

      DANISH MEDICAL BULLETIN
    37. Watine, J; Charet, JC
      Are the ATS (American Thoracic Society) and the ERS (European Respiratory Society) right in not recommending routine tumor marker assay for screening, staging or evaluation of non-small-cell lung cancer?

      REVUE DES MALADIES RESPIRATOIRES
    38. Kudoh, K; Kikuchi, Y; Kita, T; Tode, T; Takano, M; Hirata, J; Mano, Y; Yamamoto, K; Nagata, I
      Preoperative determination of several serum tumor markers in patients withprimary epithelial ovarian carcinoma

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    39. Abbasciano, V; Sartori, S; Trevisani, L; Nielsen, I; Ferrazzi, E; Bononi, A; Toso, S; Crepaldi, G; Bianchi, MP; Gilli, G; Zavagli, G
      Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specificantigen in diagnosis and response to chemotherapy of small-cell lung cancer

      CANCER DETECTION AND PREVENTION
    40. Foa, P; Fornier, M; Miceli, R; Seregni, E; Santambrogio, L; Nosotti, M; Cataldo, I; Sala, M; Caldiera, S; Bombardieri, E
      Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer

      ANTICANCER RESEARCH
    41. Khalifa, A; Mady, EA; Abadeer, N; Kamal, A
      Differential tumor markers and hepatitis markers profile in liver tumors

      ANTICANCER RESEARCH
    42. Bennink, R; Van Poppel, H; Billen, J; Decoster, M; Baert, L; Mortelmans, L; Blanckaert, N
      Serum tissue polypeptide antigen (TPA): Monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer

      ANTICANCER RESEARCH
    43. Wolff, JM; Borchers, H; Brehmer, B; Brauers, A; Jakse, G
      Cytokeratin markers in patients with prostatic diseases

      ANTICANCER RESEARCH
    44. Einarsson, R; Lei, JD; Ullrich, A; van Dalen, A
      Performance characteristics of IMMULITE (R) TPS (TM): A comparison with TPS (TM) IRMA

      ANTICANCER RESEARCH
    45. Bergqvist, M; Brattstrom, D; Hesselius, P; Wiklund, B; Silen, A; Wagenius, G; Brodin, O
      Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer

      ANTICANCER RESEARCH
    46. Southgate, J; Harnden, P; Trejdosiewicz, LK
      Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications

      HISTOLOGY AND HISTOPATHOLOGY
    47. Orntoft, TF; Vestergaard, EM
      Clinical aspects of altered glycosylation of glycoproteins in cancer

      ELECTROPHORESIS
    48. Schouwink, H; Korse, CM; Bonfrer, JMG; Hart, AAM; Baas, P
      Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma

      LUNG CANCER
    49. Tuxen, MK; Soletormos, G; Petersen, PH; Schioler, V; Dombernowsky, P
      Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer

      GYNECOLOGIC ONCOLOGY
    50. Eskelinen, M; Haglund, U
      Developments in serologic detection of human pancreatic adenocarcinoma

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    51. Sanchez-Carbayo, M; Herrero, E; Megias, J; Mira, A; Soria, F
      Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22*to detect bladder cancer

      JOURNAL OF UROLOGY
    52. Cristofori, R; Aimo, G; Mengozzi, G; Oliaro, A; Revello, F; Rapellino, M
      Tumor markers kinetic in malignant lung neoplasms

      JOURNAL OF CARDIOVASCULAR SURGERY
    53. Pina, TC; Zapata, IT; Lopez, JB; Perez, JL; Paricio, PP; Hernandez, PM
      Tumor markers in lung cancer: Does the method of obtaining the cut-off point and reference population influence diagnostic yield?

      CLINICAL BIOCHEMISTRY
    54. Nagler, RM; Barak, M; Peled, M; Ben-Aryeh, H; Filatov, M; Laufer, D
      Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1and TPS in oral squamous cell carcinoma

      CANCER
    55. Tu, DG; Wang, ST; Chang, TT; Chiu, NT; Yao, WJ
      The value of serum tissue polypeptide specific antigen in the diagnosis ofhepatocellular carcinoma

      CANCER
    56. Miedouge, M; Rouzaud, P; Salama, G; Pujazon, MC; Vincent, C; Mauduyt, MA; Reyre, J; Carles, P; Serre, G
      Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions

      BRITISH JOURNAL OF CANCER
    57. Desgrandchamps, F; Teren, M; Dal Cortivo, L; Marolleau, JP; Bertheau, P; Villette, JM; Cortesse, A; Teillac, P; Le Duc, A; Hamdy, FC
      The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer

      BRITISH JOURNAL OF CANCER
    58. RENDA A; IOVINO F; CAPASSO L; RICCIARDELLI L; TAMMARO V; ACAMPA W
      RADIOIMMUNOGUIDED SURGERY IN COLORECTAL-CANCER - A 6-YEAR EXPERIENCE WITH 4 DIFFERENT TECHNICAL SOLUTIONS

      Seminars in surgical oncology
    59. QUILLIEN V; RAOUL JL; LAURENT JF; MEUNIER B; LEPRISE E
      COMPARISON OF CYFRA-21-1, TPA AND SCC TUMOR-MARKERS IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA

      Oncology Reports
    60. TAKIYAMA I; TERASHIMA M; IKEDA K; KAWAMURA H; KASHIWABA M; TAMURA G; SUTO T; NAKASHIMA F; SASAKI R; SAITO K
      ESTABLISHMENT AND CHARACTERIZATION OF A NEW HUMAN EXTRAHEPATIC BILE-DUCT CARCINOMA CELL-LINE (ICBD-1)

      Oncology Reports
    61. Ngan, HYS; Cheung, ANY; Lauder, IJ; Chang, DKL; Wong, LC; Ma, HK
      Tumour markers and their prognostic value in adenocarcinoma of the cervix

      TUMOR BIOLOGY
    62. MAZUREK A; NIKLINSKI J; LAUDANSKI T; PLUYGERS E
      CLINICAL TUMOR-MARKERS IN OVARIAN-CANCER

      European journal of cancer prevention
    63. SLODKOWSKA J; SZTURMOWICZ M; RUDZINSKI P; GIEDRONOWICZ D; SAKOWICZ A; ANDROSIUK W; ZAKRZEWSKAROWINSKA E
      EXPRESSION OF CEA AND TROPHOBLASTIC CELL MARKERS BY LUNG-CARCINOMA INASSOCIATION WITH HISTOLOGICAL CHARACTERISTICS AND SERUM MARKER LEVELS

      European journal of cancer prevention
    64. BUCCHERI G
      DEPRESSIVE REACTIONS TO LUNG-CANCER ARE COMMON AND OFTEN FOLLOWED BY A POOR OUTCOME

      The European respiratory journal
    65. SARANDAKOU A; PHOCAS I; BOTSIS D; SIKIOTIS K; RIZOS D; KALAMBOKIS D; TRAKAKIS E; CHRYSSIKOPOULOS A
      TUMOR-ASSOCIATED ANTIGENS CEA, CA125, SCC AND TPS IN GYNECOLOGICAL CANCER

      European journal of gynaecological oncology
    66. NISMAN B; BARAK V; HECHING N; KRAMER M; REINUS C; LAFAIR J
      CYTOKERATIN MARKERS IN MALIGNANT PLEURAL MESOTHELIOMA

      Cancer detection and prevention
    67. RAY P; QUANTIN X; GRENIER J; PUJOL JL
      PREDICTIVE FACTORS OF TUMOR RESPONSE AND PROGNOSTIC FACTORS OF SURVIVAL DURING LUNG-CANCER CHEMOTHERAPY

      Cancer detection and prevention
    68. KELLER T; BITTERLICH N; HILFENHAUS S; BIGL H; LOSER T; LEONHARDT P
      TUMOR-MARKERS IN THE DIAGNOSIS OF BRONCHIAL-CARCINOMA - NEW OPTIONS USING FUZZY LOGIC-BASED TUMOR-MARKER PROFILES

      Journal of cancer research and clinical oncology
    69. BLOTTNER S; ROELANTS H
      QUANTIFICATION OF SOMATIC AND SPERMATOGENIC CELL-PROLIFERATION IN THETESTES OF RUMINANTS, USING A PROLIFERATION MARKER AND FLOW-CYTOMETRY ANALYSIS

      Theriogenology
    70. SCHUTTER EMJ; SOHN C; KRISTEN P; MOBUS V; CROMBACH G; KAUFMANN M; CAFFIER H; KREIENBERG R; VERSTRAETEN AA; KENEMANS P
      ESTIMATION OF PROBABILITY OF MALIGNANCY USING A LOGISTIC MODEL COMBINING PHYSICAL-EXAMINATION, ULTRASOUND, SERUM CA-125, AND SERUM CA-72-4 IN POSTMENOPAUSAL WOMEN WITH A PELVIC MASS - AN INTERNATIONAL MULTICENTER STUDY

      Gynecologic oncology
    71. WOLFF JM; BORCHERS H; BREHMER B; BRAUERS A; JAKSE G
      CYTOKERATIN-8 18 LEVELS IN PATIENTS WITH PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA/

      Urologia internationalis
    72. HEFLER L; TEMPFER C; HEINZL H; HAEUSLER G; STEINDL P; SCHNEEBERGER C; GITSCH G; KAINZ C
      M3 M21 SERUM LEVELS IN WOMEN WITH ADNEXAL MASSES AND INFLAMMATORY DISEASES/

      International journal of cancer
    73. FIZAZI K; COJEAN I; PIGNON JP; RIXE O; GATINEAU M; HADEF S; ARRIAGADA R; BALDEYROU P; COMOY E; LECHEVALIER T
      NORMAL SERUM NEURON-SPECIFIC ENOLASE (NSE) VALUE AFTER THE FIRST CYCLE OF CHEMOTHERAPY - AN EARLY PREDICTOR OF COMPLETE RESPONSE AND SURVIVAL IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA

      Cancer
    74. KIKKAWA F; NAWA A; TAMAKOSHI K; ISHIKAWA H; KUZUYA K; SUGANUMA N; HATTORI S; FURUI K; KAWAI M; ARII Y
      DIAGNOSIS OF SQUAMOUS-CELL CARCINOMA ARISING FROM MATURE CYSTIC TERATOMA OF THE OVARY

      Cancer
    75. NISMAN B; LAFAIR J; HECHING N; LYASS O; BARAS M; PERETZ T; BARAK V
      EVALUATION OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN, CYFRA-21-1, AND CARCINOEMBRYONIC ANTIGEN IN NONSMALL CELL LUNG-CARCINOMA - DOES THE COMBINED USE OF CYTOKERATIN MARKERS GIVE ANY ADDITIONAL INFORMATION

      Cancer
    76. TEMPFER C; HEFLER L; HEINZL H; LOESCH A; GITSCH G; RUMPOLD H; KAINZ C
      CYFRA-21-1 SERUM LEVELS IN WOMEN WITH ADNEXAL MASSES AND INFLAMMATORYDISEASES

      British Journal of Cancer
    77. REBHANDL W; RAMI B; TURNBULL J; FELBERBAUER FX; PAYA K; BANCHERTODESCA D; GHERARDINI R; MITTLBOECK M; HORCHER E
      DIAGNOSTIC-VALUE OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS) IN NEUROBLASTOMA AND WILMS-TUMOR

      British Journal of Cancer
    78. LIEBICH HM; XU G; DISTEFANO C; LEHMANN R
      CAPILLARY ELECTROPHORESIS OF URINARY NORMAL AND MODIFIED NUCLEOSIDES OF CANCER-PATIENTS

      Journal of chromatography
    79. CHEN CY; KAO CH; HSIEH YH; GU CJ
      TISSUE POLYPEPTIDE SPECIFIC ANTIGEN FOR EARLY PREDICTION OF NONSMALL CELL LUNG-CANCER RECURRENCE

      Oncology Reports
    80. BOTTINI A; BERRUTI A; TAMPELLINI M; MORRICA B; BRUNELLI A; GNOCCHI E; BRIZZI MP; AGUGGINI S; FARA E; ALQUATI P; DOGLIOTTI L
      INFLUENCE OF NEOADJUVANT CHEMOTHERAPY ON SERUM TUMOR-MARKERS CA-15-3,MCA, CEA, TPS AND TPA IN BREAST-CANCER PATIENTS WITH OPERABLE DISEASE

      Tumor biology
    81. LO SST; CHENG DKL; NG TR; WONG LC; NGAN HYS
      PROGNOSTIC-SIGNIFICANCE OF TUMOR-MARKERS IN ENDOMETRIAL CANCER

      Tumor biology
    82. PAONE G; DEANGELIS G; GRECO S; PORTALONE L; DEMARCHIS L; GALLUCCIO G; TAGLIENTI A; BISETTI A; AMEGLIO F
      EVALUATION OF RESPONSE TO CHEMOTHERAPY IN PATIENTS AFFECTED WITH NONSMALL CELL LUNG-CANCER BY MEANS OF 3 TUMOR-MARKERS ELABORATED BY DISCRIMINANT-ANALYSIS

      Respiratory medicine
    83. WILLEMSE F; NAP M; DEBRUIJN HWA; HOLLEMA H
      QUANTIFICATION OF VASCULAR DENSITY AND OF LUMEN AND VESSEL MORPHOLOGYIN ENDOMETRIAL CARCINOMA - EVALUATION OF THEIR RELATION TO SERUM LEVELS OF TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN AND CA-125

      Analytical and quantitative cytology and histology
    84. OMARY MB; KU NO
      INTERMEDIATE FILAMENT PROTEINS OF THE LIVER - EMERGING DISEASE ASSOCIATION AND FUNCTIONS

      Hepatology
    85. POLITO M; MINARDI D; RECCHIONI A; GIANNULIS I; DESIO G; MUZZONIGRO G
      SERUM MARKERS FOR MONITORING OF PROSTATIC-CARCINOMA

      The Prostate
    86. REBHANDL W; PAYA K; FELBERBAUER FX; FUCHS R; HENKEL J; BIEGLMAYER C; HORCHER E
      TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN (TPS) IN PEDIATRIC MALIGNANCIES

      Anticancer research
    87. GAARENSTROOM KN; BONFRER JMG; KORSE CM; KENTER GG; KENEMANS P
      VALUE OF CYFRA-21-1, TPA, AND SCC-AG IN PREDICTING EXTRACERVICAL DISEASE AND PROGNOSIS IN CERVICAL-CANCER

      Anticancer research
    88. SUTTERLIN M; OEHLER MK; CAFFIER H
      CLINICAL-VALUE OF CYFRA-8 18 AND TPS IN THE DIAGNOSIS AND FOLLOW-UP OF INVASIVE BREAST-CANCER/

      Anticancer research
    89. PATTARANUTAPORN P; CHANSILPA Y; TANGKARAT S; TEPMONGKOL P; SANGRUCHI S; SENAPAD S
      SERUM TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS) IN PATIENTS WITH CERVICAL-CARCINOMA - PRELIMINARY-REPORT

      Anticancer research
    90. REBHANDL W; FELBERBAUER FX; PAYA K; RAMI B; BANCHERTODESCA D; BIEGLMAYER C; HORCHER E
      TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN IN PEDIATRIC-PATIENTS - ASSESSMENT OF NORMAL VALUES

      Medical and pediatric oncology
    91. INDINNIMEO M; REALE MG; CICCHINI C; STAZI A; FIORI E; IZZO P
      CEA, TPA, CA-19-9, SCC AND CYFRA AT DIAGNOSIS AND IN THE FOLLOW-UP OFANAL-CANAL TUMORS

      International surgery
    92. KASHIWABARA K; NAKAMURA H; KIGUCHI T; YAGYU H; KISHI K; WEI BR; YONEYAMA K; MATSUOKA K
      CORRELATION BETWEEN SERUM CYTOKERATIN-19 FRAGMENT AND TISSUE POLYPEPTIDE ANTIGEN LEVELS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER

      Clinica chimica acta
    93. TEMPFER C; HEFLER L; HAEUSLER G; SLIUTZ G; HANZAL E; REINTHALLER A; KAINZ CH
      SERUM M3 M21 IN OVARIAN-CANCER PATIENTS

      British Journal of Cancer
    94. THEYER G; HOLUB S; DURER A; ANDERT S; HABERL I; THEYER U; HAMILTON G
      MEASUREMENTS OF TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC ANTIGEN IN PROSTATE-CANCER PATIENTS UNDER INTERMITTENT ANDROGEN SUPPRESSION THERAPY

      British Journal of Cancer
    95. SEREGNI E; FOA P; BOGNI A; BOTTI C; CATALDO I; SALA M; MEZZETTI M; GASPARINI M; SANTAMBROGIO L; LEGNANI D; BOMBARDIERI E
      EVALUATION OF THE SOLUBLE FRAGMENTS OF CYTOKERATIN-19 (CK19) IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - COMPARISON WITH TPA, CEA, SCC AND NSE

      Oncology Reports
    96. CORREALE M; RESHKIN SJ; TEDONE T; ABBATE I; MANGIA A; SCHITTULLI F; PARADISO A
      CYTOKERATINS AND PROLIFERATION IN BREAST-CANCER PATIENTS - EVALUATIONOF TPA LEVELS IN SERUM AND TUMOR-CELL CYTOSOL

      International journal of oncology
    97. TEDONE T; CORREALE M; PARADISO A; RESHKIN SJ
      DIFFERENTIAL RESPONSIVENESS OF PROLIFERATION AND CYTOKERATIN RELEASE TO STRIPPED SERUM AND ESTROGEN IN THE HUMAN BREAST-CANCER CELL-LINE, MCF-7

      European journal of cancer
    98. HAYDON GH; HAYES PC
      SCREENING FOR HEPATOCELLULAR-CARCINOMA

      European journal of gastroenterology & hepatology
    99. SONOO H; KUREBAYASHI J
      SERUM TUMOR-MARKER KINETICS AND THE CLINICAL COURSE OF PATIENTS WITH ADVANCED BREAST-CANCER

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    100. KUO WR; TSAI SM; JONG SB; JUAN KH
      SIGNIFICANCE OF TUMOR-MARKERS IN NASOPHARYNGEAL CARCINOMA

      Journal of otolaryngology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 02:59:33